NCT00234689已完成不适用
Efficacy of Naltrexone Treatment as Augmentation to SSRI in OCD Patients
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 试验地点
- 1
研究概览
简要总结
Assessing the efficacy of Naltrexone as augmentation to SSRI in patients with OCD
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of OCD
- •Treatment with SSRI for at least 10 weeks with no response
排除标准
- •Suffering from any medical condition
- •treatment with opiates
- •chronic use of drugs
- •Hepatitis or other liver related diseases
- •Incapability to sign an informed consent
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Ondansetron Augmentation in Treatment-resistant OCDObsessive Compulsive DisorderNCT01303536Institute of Neuroscience, Florence, Italy21
终止
2 期
Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive DisorderObsessive-Compulsive DisorderNCT00758966Orexigen Therapeutics, Inc8
已完成
2 期
Naltrexone in the Treatment of Dissociative Symptoms in Patients With Borderline Personality DisorderDissociationBorderline Personality DisorderNCT01133301Central Institute of Mental Health, Mannheim30
已完成
1 期
Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-EffectsPsychotic DisordersSchizophreniaNCT00567034Mclean Hospital30
已完成
3 期
Naltrexone & SSRI in Alcoholics With Depression/PTSDPTSDAlcoholismDepressionNCT00338962Yale University88